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c o n c i s e c o m m u n i c a t i o n
Epidemiological Analysis of Methicillin-
Resistant Staphylococcus aureus Isolates
From Adult Patients With Cystic
Fibrosis
T. J. Kidd, B Appl Sc; C. Coulter, MBBS, FRACP, FRCPA;
S. C. Bell, MBBS, MD, FRACP
Using pulsed-field gel electrophoresis, we genotyped 21 methicillin-
resistant Staphylococcus aureus isolates from patients attending an
adult cystic fibrosis unit. Eleven patients exhibited pulsotypes related
to 2 locally endemic strains. Eleven chronically colonized patients
were assessed over a period of up to 2 years, and all demonstrated
a retention of strain type.
Infect Control Hosp Epidemiol 2006; 27:201-203
Methicillin-resistant Staphylococcus aureus (MRSA) is a no-
socomially acquired organism, and infection and colonization
occur in hospitals and long-term healthcare facilities. MRSA
infection rates vary between hospitals, however; the estab-
lished risk factors for acquisition of MRSA include under-
going a surgical procedure, admission to an intensive care
unit, long-term hospitalization, and admission to healthcare
facilities with high levels of MRSA endemicity.1
The continuing colonization with MRSA of patients with
cystic fibrosis (CF) is an increasing dilemma for CF units,
where treatment options are limited. The recent North Amer-
ican Cystic Fibrosis Data Registry has reported that 6% of
children and adults with CF had MRSA isolated from respi-
ratory secretions.2 The prevalence of infection ranges widely
between CF centers in the United States, from 0% to 19.3%
of the clinic population.2 Segregation is recommended for CF
patients with MRSA infection, and infection with MRSA re-
mains a relative contraindication for lung transplantation.3,4
Limited information is currently available to define the
modes of transmission of MRSA in populations with CF. It
is not clear whether infection is spread between patients with
CF or whether infection occurs as a consequence of a com-
mon contact in accessing health care in hospitals. The aim
of this study was to examine the relatedness between MRSA
isolates collected from adults with CF and to determine the
long-term molecular epidemiology of MRSA among a group
of chronically colonized patients with CF.
materials
Setting. The Prince Charles Hospital (TPCH), located in
Brisbane, Australia, is a teaching hospital specializing in car-
diothoracic services, including open-heart surgery, thoracic
surgery, heart and lung transplantation, and thoracic medi-
cine, including the management of adult CF patients.
Study group. Twenty-one MRSA isolates from 21 patients
with CF who were treated at TPCH were included in the
study. Samples were collected during a 2-year period. Eighteen
MRSA isolates from patients without CF who originated from
healthcare facilities in southeast Queensland were included
for comparison. Multiple isolates from 11 CF patients at
TPCH who had chronic MRSA carriage were examined.
Bacterial identification and antimicrobial susceptibility test-
ing. For each MRSA isolate, identification and susceptibility
testing was performed using Microscan Conventional Positive
Panels (Dade International). Resistance to oxacillin was con-
firmed by means of disc diffusion testing (with 1-mg oxacillin
discs) on Mueller-Hinton agar at 28C, according to NCCLS
recommendations.
Pulsed-field gel electrophoresis (PFGE). All bacterial DNA
extraction and digestion was performed using the GenePath
Group 1 Reagent Kit (Bio-Rad Laboratories). Ninety mi-
croliters of an overnight culture in brain-heart infusion broth
was centrifuged at 10,000 rpm (rotor diameter, 4.5 cm) for
3 minutes. Agarose plugs were made by resuspending the
pellet in equal quantities of cell suspension buffer and em-
bedding agarose, along with lysozyme-lysostaphin, at a con-
centration of 6 mL/25 mg per mL. DNA digestion was per-
formed at 37C for 2 hours using lysozyme-lysostaphin at a
concentration of 25 mg/mL. After treatment with proteinase
K, each DNA sample underwent macrorestriction digestion
using the Sma1 enzyme at room temperature for 16-20 hours.
PFGE was performed by clamped homogenous electric fields
(CHEF) electrophoresis with a CHEF-DR II System (Bio-Rad
Laboratories). Digested DNA underwent electrophoresis in a
1.0% agarose gel at 200 V with a switch time that was grad-
ually increased from 1 to 40 seconds over 22 hours.
Strain relatedness analysis. The criteria used for deter-
mining strain relatedness were those proposed by Tenover et
al.5 Previous PFGE studies of MRSA at TPCH have illustrated
the presence of at least 2 different endemic strains.6 For the
purposes of this study, these endemic strains were termed
strain A and strain B. Each isolate was compared to the ref-
erence patterns of the endemic strains, and an assessment of
its relatedness was determined by visual comparison of band-
ing patterns (pulsotypes). Isolates with 1-3–band differences
from strain A or strain B were considered to be subtypes of
those strains. Each different subtype was designated with a
separate number (eg, A1, A2, or A3). Isolates with banding
patterns that differed from those of strain A or strain B by
more than 6 bands were considered to be individual strains
(eg, strain C or strain D). Comparison of isolates was also
performed using GelCompar software, version 4.1 (Applied
Maths). The percentage similarity of the banding patterns was
estimated with the Dice coefficient, and the matrix of similarity
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figure. Dendrogram showing the relatedness of methicillin-resistant Staphylococcus aureus isolates (left panel) obtained from patients
with cystic fibrosis at The Prince Charles Hospital Adult CF Unit, and the corresponding pulsed-field electrophoresis banding patterns of
SmaI-digested DNA samples (right panel). Relatedness and similarity values were determined as described in Methods.
coefficients was clustered by means of the unweighted pair
group method with arithmetic mean (UPGMA).
results
All MRSA isolates exhibited multidrug resistance and were
typeable by PFGE. Among the 21 MRSA isolates from CF
patients at TPCH, 12 different strains were identified. Isolates
from 3 patients exhibited a pulsotype identical to that of the
endemic strain A. One of these 3 patients was recorded as
having acquired their isolate at a separate hospital in southeast
Queensland. Isolates from an additional 7 patients demon-
strated 6 pulsotypes that differed by fewer than 4 bands; these
isolates were regarded as subtypes of strain A. One patient
harbored an isolate identical to strain B, and an additional
10 patients were colonized with unrelated strains of MRSA.
GelCompar analysis of the PFGE results highlighted 1 large
related group of PFGE patterns (175% similarity) that con-
tained 3 clusters of subtypes of strain A; the analysis also
revealed 11 distinctly unrelated PFGE patterns (!75% simi-
larity) (Figure).
Six of 11 epidemiologically unrelated isolates (ie, those
from patients without CF) from TPCH had pulsotypes that
related them to strain A (ie, subtypes A1, A5, A6, and A7).
In addition, 3 isolates from patients without CF from another
southeast Queensland healthcare facility also exhibited 2 pul-
sotypes that related them to strain A. An additional 7 isolates
belonging to strain B (including subtypes B1 and B2) that
were obtained from patients without CF at 2 southeast
Queensland hospitals (including TPCH) were also recorded.
Multiple isolates of MRSA from 11 TPCH patients with
CF were examined for relatedness. Two to four isolates per
patient were tested; these were obtained over a period of 4-
24 months (mean, 12 months). Isolates from 8 of the 11
patients demonstrated no change in pulsotype (ie, the strains
were indistinguishable). Isolates from the remaining 3 pa-
tients exhibited a change in pulsotype of only 1 band (ie, the
strains were closely related).
discussion
This study demonstrated by PFGE that there was a diversity
of MRSA strains in patients with CF at our institution. Eleven
of the 21 patients had evidence of infection with 1 of the 2
strains endemic at TPCH. However, more than 47% of iso-
lates were genetically distinct from either of these endemic
strains. In line with infection control guidelines for patients
with CF,7 patients CF and MRSA colonization or infection
are routinely admitted to a separate ward (the infectious dis-
eases ward) and attend separate outpatient clinics.
We have observed an increasing rate of chronic MRSA
colonization in the population attending our adult CF unit,
consistent with rates reported elsewhere during the past 10
years.7,8 Whether infection occurs primarily through person-
to-person spread between CF patients, as has occurred with
Burkholderia cepacia complex infection, has not been well
studied.9 Unlike B. cepacia complex, MRSA may be acquired
in hospital facilities by contact with colonized staff members
or by contact with fomites carrying MRSA.
The current study has demonstrated that there was more
than 1 MRSA strain among adults with CF receiving treat-
ment at our institution. Further, PFGE analysis of multiple
isolates indicated that patients retained the same strain of
MRSA, demonstrating clonal stability over time. These results
suggest that MRSA acquisition likely occurs in association
with attendance at this hospital. Epidemiological studies to
confirm the point of acquisition are particularly difficult to
perform in this situation, as patients attend the hospital mul-
tiple times as outpatients and/or inpatients, and they have
contact with multiple patients (including other patients with
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CF) and staff members. Although patient-to-patient spread
may still occur in some cases, strain transmission between
patients with CF does not appear to be exceedingly high,
when infection control guidelines for CF patients are applied.
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